Seguir
Suyash M. Patil, Ph.D.
Suyash M. Patil, Ph.D.
Email confirmado em thermofisher.com
Título
Citado por
Citado por
Ano
Exosomes as drug delivery systems: A brief overview and progress update
SM Patil, SS Sawant, NK Kunda
European Journal of Pharmaceutics and Biopharmaceutics, 2020
1602020
An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery
KC Petkar, SM Patil, SS Chavhan, K Kaneko, KK Sawant, NK Kunda, ...
Pharmaceutics 13 (4), 455, 2021
852021
Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro
R Vartak, SM Patil, A Saraswat, M Patki, NK Kunda, K Patel
Nanomedicine 16 (14), 1187-1202, 2021
822021
Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment
SS Sawant, SM Patil, V Gupta, NK Kunda
International Journal of Molecular Sciences 21 (20), 7575, 2020
692020
Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC)
SM Patil, SS Sawant, NK Kunda
International Journal of Pharmaceutics 607, 121046, 2021
572021
Nisin ZP, an Antimicrobial Peptide, Induces Cell Death and Inhibits Non-Small Cell Lung Cancer (NSCLC) Progression in vitro in 2D and 3D Cell Culture
SM Patil, NK Kunda
Pharmaceutical Research, 1-12, 2022
312022
Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation
SS Sawant, SM Patil, SK Shukla, NS Kulkarni, V Gupta, NK Kunda
Drug Delivery and Translational Research, 1-14, 2021
312021
Solubility Enhancement and Inhalation Delivery of Cyclodextrin-Based Inclusion Complex of Delamanid for Pulmonary Tuberculosis Treatment
SM Patil, DS Barji, T Chavan, K Patel, AJ Collazo, V Prithipaul, A Muth, ...
AAPS PharmSciTech 24 (1), 49, 2023
132023
Anticancer activity of D-LAK-120A, an antimicrobial peptide, in non-small cell lung cancer (NSCLC)
SM Patil, NK Kunda
Biochimie 201, 7-17, 2022
122022
Pulmonary delivery of spray-dried Nisin ZP antimicrobial peptide for non-small cell lung cancer (NSCLC) treatment
SM Patil, DS Barji, S Aziz, DA McChesney, S Bagde, P Muttil, NK Kunda
International Journal of Pharmaceutics 634, 122641, 2023
82023
A quality-by-design strategic approach for the development of bedaquiline-pretomanid nanoparticles as inhalable dry powders for TB treatment
SM Patil, AM Diorio, P Kommarajula, NK Kunda
International Journal of Pharmaceutics 653, 123920, 2024
42024
Pulmonary delivery of bedaquiline-loaded cubosomes for non-small cell lung cancer (NSCLC) treatment
SM Patil, SS Sawant, NK Kunda
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 35 (2), A4-A4, 2022
32022
Design of Experiment (DoE) Approach for Developing Inhalable PLGA Microparticles Loaded with Clofazimine for Tuberculosis Treatment
DS Rongala, SM Patil, NK Kunda
Pharmaceuticals 17 (6), 754, 2024
12024
Oral inhalation of dacomitinib nanocarriers as a therapeutic strategy for non-small cell lung cancer
DS Rongala, SM Patil, NK Kunda
Nanomedicine 19 (18-20), 1601-1613, 2024
2024
A QUALITY-BY-DESIGN APPROACH FOR THE DEVELOPMENT OF INHALABLE DRY POWDERS FOR TUBERCULOSIS (TB) TREATMENT
SM Patil
2024
Formulation Development of Inhalable Dacomitinib Polymeric Nanoparticles for Non-Small Cell Lung Cancer Treatment
D Barji, SM Patil, NK Kunda
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 35 (2), A18-A19, 2022
2022
Development of Inhalable Nisin ZP Dry Powder for Non-small Cell Lung Cancer Treatment
SM Patil, DS Barji, NK Kunda
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 33, A37-A40, 2022
2022
Aerosolized Nanoliposomal Carrier of Remdesivir (AL-Rem) – A Potential Alternative to the Existing Covid-19 Treatment
RV Vartak, SM Patil, AL Saraswat, MP Patki, NK Kunda, KD Patel
Respiratory Drug Delivery 2021, 277-281, 2021
2021
Formulation Development of Inhalable Osimertinib Liposomes for the Treatment of Non-Small Cell Lung Cancer
SS Sawant, SM Patil, NK Kunda
Respiratory Drug Delivery 2021, 1-5, 2021
2021
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–19